# Josefin Blomkvist

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/josefin-blomkvist/

## Facts

| Field | Value |
| --- | --- |
| Citations | 360 |
| Field | Head and Neck Cancer Studies |
| h-index | 5 |
| i10-index | 5 |
| Last Known Institution | Swedish Orphan Biovitrum (Sweden) |
| OpenAlex ID | https://openalex.org/A5029836623 |
| Works | 13 |

## Researcher papers

- [The Volume-Outcome Relationship in Critical Care](https://scholariq.org/papers/the-volume-outcome-relationship-in-critical-care/)
- [The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials](https://scholariq.org/papers/the-influence-of-anti-infective-periodontal-treatment-on-c-reactive-protein-a/)
- [Cost-Effectiveness of Left Ventricular Assist Devices for Patients with End-Stage Heart Failure: Analysis of the French Hospital Discharge Database](https://scholariq.org/papers/cost-effectiveness-of-left-ventricular-assist-devices-for-patients-with-end/)
- [Perspective on Roseroot<i>(Rhodiola rosea)</i>Studies](https://scholariq.org/papers/perspective-on-roseroot-i-rhodiola-rosea-i-studies/)
- [Clinical and economic impact of treated CMV infection in adult CMV‐seropositive patients after allogeneic hematopoietic cell transplantation](https://scholariq.org/papers/clinical-and-economic-impact-of-treated-cmv-infection-in-adult-cmv-seropositive/)
- [Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.](https://scholariq.org/papers/phase-i-trial-of-hafnium-oxide-nanoparticles-activated-by-radiotherapy-in/)
- [Preliminary development of a tool assessing the acceptability of medicines for paediatric use](https://scholariq.org/papers/preliminary-development-of-a-tool-assessing-the-acceptability-of-medicines-for/)
- [NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Cisplatin-Ineligible Patients With Locally Advanced HNSCC: A Phase I Trial](https://scholariq.org/papers/nbtxr3-radiation-enhancing-hafnium-oxide-nanoparticles-activated-by-radiotherapy/)
- [OP0207 EFFICACY AND SAFETY OF EMAPALUMAB IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME IN STILL'S DISEASE: RESULTS FROM A POOLED ANALYSIS OF TWO PROSPECTIVE TRIALS](https://scholariq.org/papers/op0207-efficacy-and-safety-of-emapalumab-in-patients-with-macrophage-activation/)
- [Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation](https://scholariq.org/papers/clinical-outcome-associated-with-cytomegalovirus-cmv-infection-disease-in-cmv/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)
- [Social and Educational Sciences](https://scholariq.org/topics/social-and-educational-sciences/)
- [Corporate Social Responsibility Reporting](https://scholariq.org/topics/corporate-social-responsibility-reporting/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)

## Researcher university

- [Swedish Orphan Biovitrum (Sweden)](https://scholariq.org/institutions/swedish-orphan-biovitrum-sweden/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.